CrushSCI.com
Journal Selection & Manuscript Polishing Services
PHARMACOGENOMICS journal cover Medicine
Back to journal directory

Review Cycle Records

PHARMACOGENOMICS

Taylor & Francis SCIE Non-OA
2026 Emerging Zone 42025 CAS Zone 42025 JCR Q3
101.7Average days
90.5Median days
22Fastest days
248Longest days
722025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

248 days

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations

AuthorsMohamed Nagy; Gerard Marshall Raj; Rekha Priyadarshini; Luis Abel Quiñones; Amit Kumar Mitra; Lay Kek Teh; Aniwaa Owusu-Obeng; Ben Kong; Folefac Aminkeng; Collen Masimirembwa; Chakradhara Rao Satyanarayana Uppugunduri

Affiliations1. Children’s Cancer Hospital Egypt; 2. All India Institute of Medical Sciences (AIIMS) Bibinagar; 3. University of Chile; 4. Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED); 5. Auburn University, Auburn, AL, USA; 6. Auburn University; 7. University of Alabama at Birmingham (UAB); 8. Universiti Teknologi MARA Selangor Branch (UCS); 9. Universiti Teknologi MARA (UiTM); 10. Universiti Teknologi MARA (UiTM) Cawangan Selangor; 11. Icahn School of Medicine at Mount Sinai; 12. Oregon Health & Science University; 13. Jude Children’s Research Hospital; 14. National University of Singapore (NUS); 15. National University Health System (NUHS); 16. African Institute of Biomedical Science and Technology (AiBST); 17. Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)

Source PDF DOI Publisher page
91 days

U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole

AuthorsBrock Beins; Hans Salcedo; Gloria Grice; Cyrielle Billon

Affiliations1. University of Health Sciences and Pharmacy; 2. St. Louis College of Pharmacy; 3. Washington University School of Medicine

Source PDF DOI Publisher page
142 days

Association of ACE I/D polymorphism with blood pressure response to valsartan-hydrochlorothiazide combination therapy in hypertensive patients from Khyber Pakhtunkhwa, Pakistan

AuthorsAftab Ullah; Abdur Rahim; Asif Jan; Muhammad Khan; Junaid Iqbal; Mequanente Dagnaw

Affiliations1. Hazara University Mansehra; 2. CECOS University of IT & Emerging Sciences; 3. District Headquarter Hospital Charsadda; 4. Saidu Group of Teaching Hospitals (SGTH); 5. University of Peshawar; 6. Hazara University; 7. Qurtaba University; 8. University of Gondar

Source PDF DOI Publisher page
44 days

Impact of NAT2 acetylation phenotype on toxicity in tuberculosis therapy: a systematic review and meta-analysis

AuthorsSofia Dinegro; Sara Dal Molin; Ilaria Mariani; Giulia Mosini; Marco Schiuma; Alessandro Torre; Agostino Riva; Andrea Gori; Emilio Clementi; Sonia Radice; Stefania Cheli

Affiliations1. ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Università degli Studi di Milano; 2. ASST Fatebenefratelli Sacco, Luigi Sacco Hospital; 3. University of Milan; 4. Scientific Institute IRCCS E. Medea

Source PDF DOI Publisher page
115 days

Evaluation of dopamine transporter gene variations in Turkish children with attention deficit hyperactivity disorder treated with methylphenidate adverse effects

AuthorsKubra Cigdem Pekkoc-Uyanik; Melik Yigit Bayindir; Muhammet Fatih Akdemir; Aybike Aydin Okuyan; Mahmut Cem Tarakcioglu; Sibel Ozyazgan; Zeynep Gizem Todurga Seven

Affiliations1. Haliç University; 2. Istanbul University-Cerrahpasa

Source PDF DOI Publisher page
165 days

Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV

AuthorsZinhle Cindi; Katie M. Cardone; Yuki Bradford; Molly A. Hall; Hannah Kim; Eric S. Daar; Roy Gulick; Sharon A. Riddler; Marijana Vujkovic; Kyong-Mi Chang; Philip S. Tsao; Phumla Sinxadi; David W. Haas; Marylyn D. Ritchie; VA Million Veteran Program

Affiliations1. University of Pennsylvania; 2. Vanderbilt University Medical Center; 3. Lundquist Institute at Harbor-UCLA Medical Center; 4. Weill Cornell Medicine; 5. University of Pittsburgh; 6. Corporal Michael J. Crescenz VA Medical Center; 7. University of Pennsylvania Perelman School of Medicine; 8. VA Palo Alto Health Care System; 9. Stanford University School of Medicine; 10. University of Cape Town; 11. South African Medical Research Council; 12. Meharry Medical College; 13. Medical University of South Carolina

Source PDF DOI Publisher page
75 days

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial

AuthorsAniket Chawla; Sean Carter; Roxanne Dyas; Elizabeth Williams; Claire Moore; Rachel Conyers

Affiliations1. Murdoch Children’s Research Institute; 2. The Royal Children’s Hospital; 3. University of Melbourne

Source PDF DOI Publisher page
22 days

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use

AuthorsBernhard T. Baune

Affiliations1. University of Münster and University Hospital Münster; 2. University of Western Australia; 3. University of Melbourne

Source PDF DOI Publisher page
71 days

Closely similar tacrolimus morning troughs and graft function across the recipients’ common ABCB1 polymorphisms ( c.2677G>T/A , c.1236C>T , c.3435C>T ) early after renal transplantation

AuthorsLuka Penezić; Sandra Nađ Škegro; Lana Ganoci; Livija Šimičević; Mila Lovrić; Nada Božina; Vladimir Trkulja

Affiliations1. University Hospital Center Zagreb; 2. University of Zagreb School of Medicine

Source PDF DOI Publisher page
115 days

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: “It’s no different from your blood type”

AuthorsColene Bentley; Louisa Edwards; Kieran C. O’Doherty; Stirling Bryan; Jehannine (J9) Austin

Affiliations1. Consultant; 2. University of British Columbia; 3. University of Guelph

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.